EXAS
NASDAQ · Biotechnology
Exact Sciences Corp
$104.91
+0.99 (+0.95%)
Analyst Consensus
Hold
29
Analysts
High
Coverage
Price Target
Analyst Price Target
+24.6% upside
Low Target
$80.73
Average Target
$130.71
High Target
$205.54
Current Price
$104.91
Current
$104.91
$104.91
Target
$130.71
$130.71
$80.73
$130.71 avg
$205.54
Scenario Analysis
Bear Case
$80.73
-23.0%
Low target
Base Case
$130.71
+24.6%
Avg target
Bull Case
$205.54
+95.9%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$104.98
-0.1% from high
52-Week Low
$64.02
+63.9% from low
50-Day SMA
$103.09
+1.8% vs SMA
200-Day SMA
$74.54
+40.7% vs SMA
RSI (14)
73.6
Overbought
Target vs 52W High
$130.71
+24.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |